IRIS Accounts Production v24.1.0.578 07417549 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074175492022-12-31074175492023-12-31074175492023-01-012023-12-31074175492021-12-31074175492022-01-012022-12-31074175492022-12-3107417549ns15:EnglandWales2023-01-012023-12-3107417549ns14:PoundSterling2023-01-012023-12-3107417549ns10:Director12023-01-012023-12-3107417549ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3107417549ns10:SmallEntities2023-01-012023-12-3107417549ns10:AuditExemptWithAccountantsReport2023-01-012023-12-3107417549ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3107417549ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3107417549ns10:FullAccounts2023-01-012023-12-3107417549ns10:Director22023-01-012023-12-3107417549ns10:CompanySecretary12023-01-012023-12-3107417549ns10:RegisteredOffice2023-01-012023-12-3107417549ns5:CurrentFinancialInstruments2023-12-3107417549ns5:CurrentFinancialInstruments2022-12-3107417549ns5:Non-currentFinancialInstruments2023-12-3107417549ns5:Non-currentFinancialInstruments2022-12-3107417549ns5:ShareCapital2023-12-3107417549ns5:ShareCapital2022-12-3107417549ns5:SharePremium2023-12-3107417549ns5:SharePremium2022-12-3107417549ns5:RetainedEarningsAccumulatedLosses2023-12-3107417549ns5:RetainedEarningsAccumulatedLosses2022-12-3107417549ns5:LandBuildings2022-12-3107417549ns5:PlantMachinery2022-12-3107417549ns5:LandBuildings2023-01-012023-12-3107417549ns5:PlantMachinery2023-01-012023-12-3107417549ns5:LandBuildings2023-12-3107417549ns5:PlantMachinery2023-12-3107417549ns5:LandBuildings2022-12-3107417549ns5:PlantMachinery2022-12-3107417549ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2022-12-3107417549ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-12-3107417549ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2022-12-3107417549ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3107417549ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3107417549ns5:WithinOneYear2023-12-3107417549ns5:WithinOneYear2022-12-3107417549ns5:BetweenOneFiveYears2023-12-3107417549ns5:BetweenOneFiveYears2022-12-3107417549ns5:AllPeriods2023-12-3107417549ns5:AllPeriods2022-12-31074175491ns10:Director12022-12-31074175491ns10:Director12021-12-31074175491ns10:Director12023-01-012023-12-31074175491ns10:Director12022-01-012022-12-31074175491ns10:Director12023-12-31074175491ns10:Director12022-12-31
REGISTERED NUMBER: 07417549 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2023

for

Beyond Health Limited

Beyond Health Limited (Registered number: 07417549)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Report of the Accountants 7

Beyond Health Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: J A Lawrence
Ms C E Burrowes





SECRETARY: Ms C E Burrowes





REGISTERED OFFICE: Level 3
Brigade House
8 Parsons Green
London
SW6 4TN





REGISTERED NUMBER: 07417549 (England and Wales)





ACCOUNTANTS: Gwynne-Evans & Co Limited
Chartered Accountants
49 Sandy Lodge Way
Northwood
Middlesex
HA6 2AR

Beyond Health Limited (Registered number: 07417549)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 402,632 232,818

CURRENT ASSETS
Debtors 5 129,730 87,643
Cash in hand 62,795 60,591
192,525 148,234
CREDITORS
Amounts falling due within one year 6 154,059 229,990
NET CURRENT ASSETS/(LIABILITIES) 38,466 (81,756 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

441,098

151,062

CREDITORS
Amounts falling due after more than one
year

7

338,000

132,000
NET ASSETS 103,098 19,062

CAPITAL AND RESERVES
Called up share capital 4,001 4,001
Share premium 333 333
Retained earnings 98,764 14,728
SHAREHOLDERS' FUNDS 103,098 19,062

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Beyond Health Limited (Registered number: 07417549)

Balance Sheet - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 August 2024 and were signed on its behalf by:





J A Lawrence - Director


Beyond Health Limited (Registered number: 07417549)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Beyond Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2022 - 15 ) .

Beyond Health Limited (Registered number: 07417549)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 January 2023 11,143 548,577 559,720
Additions - 203,953 203,953
At 31 December 2023 11,143 752,530 763,673
DEPRECIATION
At 1 January 2023 1,508 325,394 326,902
Charge for year 743 33,396 34,139
At 31 December 2023 2,251 358,790 361,041
NET BOOK VALUE
At 31 December 2023 8,892 393,740 402,632
At 31 December 2022 9,635 223,183 232,818

Fixed assets, included in the above, which are held under hire purchase contracts or finance leases are as follows:

Plant and
machinery
etc
£   
COST
At 1 January 2023
and 31 December 2023 71,933
DEPRECIATION
At 1 January 2023
and 31 December 2023 26,257
NET BOOK VALUE
At 31 December 2023 45,676
At 31 December 2022 45,676

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 36,478 44,227
Other debtors 93,252 43,416
129,730 87,643

Beyond Health Limited (Registered number: 07417549)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors 52,199 69,886
Taxation and social security 24,638 53,138
Other creditors 77,222 106,966
154,059 229,990

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.23 31.12.22
£    £   
Other creditors 338,000 132,000

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31.12.23 31.12.22
£    £   
Within one year 155,049 85,329
Between one and five years 364,209 199,101
519,258 284,430

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2023 and 31 December 2022:

31.12.23 31.12.22
£    £   
J A Lawrence
Balance outstanding at start of year - -
Amounts advanced 402 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 402 -

Interest has been charged at the official rate on outstanding balances throughout the period with the balance repaid in full by the date of signing these accounts.

Beyond Health Limited

Report of the Accountants to the Directors of
Beyond Health Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 December 2023 set out on pages three to eight and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Gwynne-Evans & Co Limited
Chartered Accountants
49 Sandy Lodge Way
Northwood
Middlesex
HA6 2AR


13 August 2024